Evidence map›Paper›PMID 26276821›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2015

Axl modulates immune activation of smooth muscle cells in vein graft remodeling.

Sri N Batchu, Jixiang Xia, Kyung Ae Ko, Marvin M Doyley, Jun-Ichi Abe, Craig N Morrell, Vyacheslav A Korshunov

Abstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Bone marrow-derived AXL tyrosine kinase promotes mitogenic crosstalk and cardiac allograft vasculopathy.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2021
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. TAM receptors in cardiovascular disease.Cardiovascular research · 2019
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Role of Axl in T-Lymphocyte Survival in Salt-Dependent Hypertension.Arteriosclerosis, thrombosis, and vascular biology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sri N BatchuDepartment of Medicine, Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, New York; and.
Jixiang XiaDepartment of Medicine, Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, New York; and.
Kyung Ae KoDepartment of Medicine, Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, New York; and.
Marvin M DoyleyDepartment of Electrical and Computer Engineering, University of Rochester and Hajim School of Engineering and Applied Sciences, Rochester, New York; and.
Jun-Ichi AbeUniversity of Texas MD Anderson Cancer Center, Houston, Texas.
Craig N MorrellDepartment of Medicine, Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, New York; and.
Vyacheslav A KorshunovDepartment of Medicine, Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, New York; and Department of Biomedical Genetics, University of Rochester School of Medicine and Dentistry, Rochester, New York; Slava_Korshunov@urmc.rochester.edu.
University of Rochester · USThe University of Texas MD Anderson Cancer Center · US

Funding

Novel platelet functions for in T-cell helper cell responsesR01HL124018 · NHLBI · UNIVERSITY OF ROCHESTER · PI MORRELL, CRAIG N · 2015 to 2018
$1.5M
The Role of Immune Response in Vascular Dysfunction in HypertensionR01HL105623 · NHLBI · UNIVERSITY OF ROCHESTER · PI KORSHUNOV, VYACHESLAV A · 2011 to 2015
$1.5M
NHLBI NIH HHS HL-105623NHLBI NIH HHS R01 HL105623NHLBI NIH HHS R01 HL124018
6 · The paper itself

Abstract

The pathophysiological mechanisms of the immune activation of smooth muscle cells are not well understood. Increased expression of Axl, a receptor tyrosine kinase, was recently found in arteries from patients after coronary bypass grafts. In the present study, we hypothesized that Axl-dependent immune activation of smooth muscle cells regulates vein graft remodeling. We observed a twofold decrease in intimal thickening after vascular and systemic depletion of Axl in vein grafts. Local depletion of Axl had the greatest effect on immune activation, whereas systemic deletion of Axl reduced intima due to an increase in apoptosis in vein grafts. Primary smooth muscle cells isolated from Axl knockout mice had reduced proinflammatory responses by prevention of the STAT1 pathway. The absence of Axl increased suppressor of cytokine signaling (SOCS)1 expression in smooth muscle cells, a major inhibitory protein for STAT1. Ultrasound imaging suggested that vascular depletion of Axl reduced vein graft stiffness. Axl expression determined the STAT1-SOCS1 balance in vein graft intima and progression of the remodeling. The results of this investigation demonstrate that Axl promotes STAT1 signaling via inhibition of SOCS1 in activated smooth muscle cells in vein graft remodeling.

Indexed as

AnimalsAortaApoptosisAxl Receptor Tyrosine KinaseCarotid ArteriesMiceMice, KnockoutMuscle, Smooth, VascularMyocytes, Smooth MuscleProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesReverse Transcriptase Polymerase Chain ReactionSignal TransductionSTAT1 Transcription FactorSuppressor of Cytokine Signaling 1 ProteinSuppressor of Cytokine Signaling ProteinsAxl Receptor Tyrosine KinaseAXL receptor tyrosine kinase, mouseProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesSocs1 protein, mouseStat1 protein, mouseSTAT1 Transcription FactorSuppressor of Cytokine Signaling 1 ProteinSuppressor of Cytokine Signaling ProteinsAxlinflammationsmooth muscle cellvascular remodeling

Identifiers

PMID26276821
PMCPMC4591360
OpenAlexW1929087641

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.